Acute kidney injury in pediatric hematopoietic cell transplantation: critical appraisal and consensus

Title

Acute kidney injury in pediatric hematopoietic cell transplantation: critical appraisal and consensus

Creator

Rupesh Raina
Rolla Abu-Arja
Sidharth Sethi
Richa Dua
Ronith Chakraborty
James T Dibb
Rajit K Basu
John Bissler
Melvin Bonilla Felix
Patrick Brophy
Timothy Bunchman
Khalid Alhasan
Dieter Haffner
Yap Hui Kim
Christopher Licht
Mignon McCulloch
Shina Menon
Ali Mirza Onder
Prajit Khooblall
Amrit Khooblall
Veronika Polishchuk
Hemalatha Rangarajan
Azmeri Sultana
Clifford Kashtan

Date

2022

Description

Hematopoietic cell transplantation (HCT) is a common therapy for the treatment of neoplastic and metabolic disorders, hematological diseases, and fatal immunological deficiencies. HCT can be subcategorized as autologous or allogeneic, with each modality being associated with their own benefits, risks, and post-transplant complications. One of the most common complications includes acute kidney injury (AKI). However, diagnosing HCT patients with AKI early on remains quite difficult. Therefore, this evidence-based guideline, compiled by the Pediatric Continuous Renal Replacement Therapy (PCRRT) working group, presents the various factors that contribute to AKI and recommendations regarding optimization of therapy with minimal complications in HCT patients.

Source

Pediatr Nephrol
. 2022 Jun;37(6):1179-1203. doi: 10.1007/s00467-022-05448-x. Epub 2022 Feb 28.

Language

English

Citation

Rupesh Raina et al., “Acute kidney injury in pediatric hematopoietic cell transplantation: critical appraisal and consensus,” NEOMED Bibliography Database, accessed January 23, 2025, https://neomed.omeka.net/items/show/12038.